Comparison of two highly automated DNA extraction systems for quantifying Epstein-Barr virus in whole blood

Journal of Clinical Virology

Volumn 43, Issue 3, 2008, Pages 272-276

  Mengelle, C ^a   Legrand Abravanel, F ^a   Mansuy, J M ^a   Barthe, C ^a   Da Silva, I ^a   Izopet, J ^a  

^a CH Toulouse ^*  (France)

Author keywords

Automated; Epstein Barr virus; Extraction; Real time PCR

Indexed keywords

ARTICLE; BLOOD; CONTROLLED STUDY; DNA EXTRACTION; EPSTEIN BARR VIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

AUTOMATION; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 53849092682     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.08.005     Document Type: Article

References (26)

1. Guthery S.L., Heubi J.E., Bucuvalas J.C., Gross T.G., Ryckman F.C., Alonso M.H., et al. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Transplantation 75 (2003) 987-993
2. Micallef I.N., Chhanabhai M., Gascoyne R.D., Shepherd J.D., Fung H.C., Nantel S.H., et al. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience. Bone Marrow Transplant 22 (1998) 981-987
3. Gross T.G., Steinbuch M., DeFor T., Shapiro R.S., McGlave P., Ramsay N.K., et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant 23 (1999) 251-258
4. Fellner M.D., Durand K., Correa R.M., Redini L., Yampolsky C., Colobraro A., et al. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Int J Infect Dis 11 (2007) 172-178
5. Bonnet F., Jouvencel A.C., Parrens M., Leon M.J., Cotto E., Garrigue I., et al. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. J Clin Virol 36 (2006) 258-263
6. Verschuuren E., van der Bij W., de Boer W., Timens W., Middeldorp J., and The T.H. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. J Med Virol 69 (2003) 258-266
7. Bai X., Hosler G., Rogers B.B., Dawson D.B., and Scheuermann R.H. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin Chem 43 (1997) 1843-1849
8. Meerbach A., Gruhn B., Egerer R., Reischl U., Zintl F., and Wutzler P. Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases. J Med Virol 65 (2001) 348-357
9. van Esser J.W., van der Holt B., Meijer E., Niesters H.G., Trenschel R., Thijsen S.F., et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98 (2001) 972-978
10. Baldanti F., Grossi P., Furione M., Simoncini L., Sarasini A., Comoli P., et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 38 (2000) 613-619
11. Stevens S.J., Blank B.S., Smits P.H., Meenhorst P.L., and Middeldorp J.M. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. Aids 16 (2002) 993-1001
12. Stevens S.J., Verschuuren E.A., Verkuujlen S.A., Van Den Brule A.J., Meijer C.J., and Middeldorp J.M. Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease. Leuk Lymphoma 43 (2002) 831-840
13. Brengel-Pesce K., Morand P., Schmuck A., Bourgeat M.J., Buisson M., Bargues G., et al. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol 66 (2002) 360-369
14. Jebbink J., Bai X., Rogers B.B., Dawson D.B., Scheuermann R.H., and Domiati-Saad R. Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons. J Mol Diagn 5 (2003) 15-20
15. Gulley M.L., Fan H., and Elmore S.H. Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting. J Mol Diagn 8 (2006) 589-597
16. Loginov R., Aalto S., Piiparinen H., Halme L., Arola J., Hedman K., et al. Monitoring of EBV-DNAemia by quantitative real-time PCR after adult liver transplantation. J Clin Virol 37 (2006) 104-108
17. Stevens S.J., Verschuuren E.A., Pronk I., van Der Bij W., Harmsen M.C., The T.H., et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97 (2001) 1165-1171
18. Stevens S.J., Pronk I., and Middeldorp J.M. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 39 (2001) 1211-1216
19. Wada K., Kubota N., Ito Y., Yagasaki H., Kato K., Yoshikawa T., et al. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol 45 (2007) 1426-1432
20. Fafi-Kremer S., Brengel-Pesce K., Bargues G., Bourgeat M.J., Genoulaz O., Seigneurin J.M., et al. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. J Clin Virol 30 (2004) 157-164
21. Wadowsky R.M., Laus S., Green M., Webber S.A., and Rowe D. Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol 41 (2003) 5245-5249
22. Kozic S., Vince A., Bes J.I., Rode O.D., Lepej S.Z., Poljak M., et al. Evaluation of a commercial real-time PCR assay for quantitation of Epstein-Barr virus DNA in different groups of patients. J Virol Methods 135 (2006) 263-268
23. Hill C.E., Harris S.B., Culler E.E., Zimring J.C., Nolte F.S., and Caliendo A.M. Performance characteristics of two real-time PCR assays for the quantification of Epstein-Barr virus DNA. Am J Clin Pathol 125 (2006) 665-671
24. Hakim H., Gibson C., Pan J., Srivastava K., Gu Z., Bankowski M.J., et al. Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus (EBV) in peripheral blood. J Clin Microbiol 45 (2007) 2151-2155
25. Mengelle C., Sandres-Saune K., Pasquier C., Rostaing L., Mansuy J.M., Marty M., et al. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol 41 (2003) 3840-3845
26. Beuselinck K., van Ranst M., and van Eldere J. Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR. J Clin Microbiol 43 (2005) 5541-5546